NEORx VERLUMA IMAGING AGENT FOR INITIAL STAGING OF SMALL CELL LUNG CANCER ACCURATE IN 82% OF PATIENTS; GAINS RECOMMENDATION FROM FDA COMMITTEE.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".